Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
Fig.7.F,G
Kowalczyk I et al. (2021) |
Xla Wt + gipc1 MO + lrp2 MO
NF16 (immunohistochemistry) |
|
||||||
Movie 2
Kowalczyk I et al. (2021) |
Xla Wt + lrp2 MO
NF14-16 (immunohistochemistry) |
|
||||||
Fig.7.D,G
Kowalczyk I et al. (2021) |
Xla Wt + lrp2 MO
NF16 (immunohistochemistry) |
|
||||||
Fig.3.A,A1,C,E,C1,J
Kowalczyk I et al. (2021) |
Xla Wt + lrp2 MO
NF16 (immunohistochemistry) |
|
||||||
Fig.S3
Kowalczyk I et al. (2021) |
Xla Wt + lrp2 MO
NF16 (immunohistochemistry) |
|
||||||
Fig.4.E,I,I'
Kowalczyk I et al. (2021) |
Xla Wt + lrp2 MO
NF19 (immunohistochemistry) |
|
||||||
Fig.2.J,J''
Kowalczyk I et al. (2021) |
Xla Wt + lrp2 MO
NF19 (whole-mount microscopy) |
|